Archives
-
CTP Solution for Robust p21 mRNA-LNP Workflows
2026-09-22
A defined Cytidine-5'-triphosphate input can make IVT development more reproducible, from reporter mRNA assays to exploratory p21 mRNA-LNP studies. This guide connects nucleotide handling, RNA quality control, localized delivery models, and practical troubleshooting without equating an upstream reagent with therapeutic efficacy.
-
Dextromethorphan hydrobromide Assay Guide
2026-09-22
A scenario-based guide to using Dextromethorphan hydrobromide (SKU B3478) in cell viability, cytotoxicity, and neuroprotection workflows. It connects mechanism, solution preparation, assay controls, data interpretation, and practical supplier selection without overstating evidence.
-
WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis
2026-09-21
The reference study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors. By integrating pharmacological screening, mass cytometry, transcriptomics, and network modeling, it connects β-catenin stabilization with reduced fat formation and improved support of muscle regeneration.
-
Protein A/G Magnetic Co-IP/IP Kit Workflow
2026-09-21
Translate genomic interaction candidates into practical IP, co-IP, and mass spectrometry workflows with magnetic separation. The Protein A/G Magnetic Co-IP/IP Kit combines Fc-compatible capture, streamlined washing, and flexible sample handling for protein complex isolation and antibody purification.
-
Ziprasidone Targets GOT1 in Pancreatic Cancer
2026-09-20
A 2022 Journal of Molecular Medicine study identifies ziprasidone as a noncompetitive inhibitor of GOT1, a metabolic enzyme that supports glutamine utilization and redox balance in pancreatic ductal adenocarcinoma. By combining biochemical, cellular, metabolomic, genetic, and xenograft experiments, the authors show that GOT1 inhibition disrupts tumor-cell metabolism and limits PDAC growth.
-
T0070907: A Mechanistic Lens on PPARγ Translation
2026-09-19
T0070907 is more than a potent PPARγ antagonist: it is a mechanistic tool for separating receptor-dependent transcription from downstream phenotypes in adipogenesis, inflammation, and cancer biology. This article connects its covalent receptor engagement with the RXRα/PPARγ/NEDD4 findings reported in atherosclerosis and outlines a translational workflow for pathway validation.
-
Podophyllotoxin Derivative 5p Overcomes MDR
2026-09-18
The reference study identifies 5p, a 4β-N-substituted Podophyllotoxin derivative, as a dual inhibitor of topoisomerase IIα and microtubule polymerization with activity in drug-resistant cancer models. Its value lies in connecting target engagement with transporter regulation, G2/M arrest, apoptosis, pyroptosis-associated signaling, and suppression of resistant tumor growth.
-
SM-102 (C1042) for Reliable mRNA Assays
2026-09-18
Learn how SM-102 (SKU C1042) can help researchers control formulation, solvent, storage, and interpretation variables in mRNA lipid nanoparticle assays. This scenario-based guide connects product specifications with practical viability and proliferation workflows without overstating formulation-specific performance.
-
Zoledronic Acid: From Apoptosis to Translation
2026-09-17
A translational framework for using Zoledronic Acid to connect cancer-cell apoptosis assays, breast cancer and multiple myeloma models, and osteolytic bone disease research while preserving mechanistic and formulation rigor.
-
EdU Imaging Kits (Cy5): Practical Workflow Guide
2026-09-17
EdU Imaging Kits (Cy5) provide a practical way to measure DNA synthesis during S-phase using Cy5 click-chemistry detection for microscopy or flow cytometry. This guide explains setup, controls, and troubleshooting while noting that the assay reports EdU incorporation during a defined labeling window rather than total proliferation, viability, or genotoxicity by itself.
-
5-Methyl-CTP for Optimized mRNA Synthesis
2026-09-16
Build more informative in vitro transcription screens with 5-Methyl-CTP, a titratable cytidine analog for testing mRNA stability and translation. The workflow connects reagent handling and molecular QC with lessons from an H5N1 mRNA vaccine study in lactating dairy cows.
-
Alosetron Workflows for 5-HT3 GI Research
2026-09-16
Build controlled gastrointestinal assays that separate 5-HT3 receptor pharmacology from CDC42–YAP–mTOR polarity signaling. This practical Alosetron workflow covers organoid design, epithelial barrier readouts, dosing controls, and troubleshooting without overstating an untested mechanistic link.
-
ddhCTP: From Viperin Biology to Antiviral Strategy
2026-09-15
ddhCTP is more than a nucleotide analog: it is a mechanistic probe for testing how viral polymerases respond to host-generated chain termination. This article connects Viperin biology, coronavirus replication-complex disruption, assay design, and translational strategy for researchers developing RNA virus inhibitors.
-
Protein A/G Magnetic Co-IP/IP Kit for Mechanism
2026-09-15
Use the Protein A/G Magnetic Co-IP/IP Kit to convert protein-interaction hypotheses into rigorous, reproducible experiments. This guide applies the workflow to the BATF2–ATF3 mitochondrial mechanism in intervertebral disc degeneration while clarifying controls, assay limits, and downstream MS strategy.
-
Etoposide (VP-16): From DNA Breaks to Genome Defense
2026-09-14
Etoposide (VP-16) is more than a benchmark topoisomerase II poison: it is a controllable DNA damage stressor for investigating double-strand break signaling, apoptosis, and nuclear genome-defense networks. This thought-leadership guide connects Etoposide experimental design with emerging evidence that nuclear cGAS suppresses LINE-1 retrotransposition through a CHK2–cGAS–TRIM41–ORF2p axis.